Stojanovic M, Sternic N, Kostic V S
Institute for Neurology CCS, Belgrade, Yugoslavia.
Clin Neuropharmacol. 1997 Apr;20(2):171-4. doi: 10.1097/00002826-199704000-00010.
Hemiballism is a relatively rare hyperkinetic disorder; treatment is based mainly on neuroleptics and drugs that decrease release of dopamine. We report the cases of two patients with hemiballism. After a period of 1 month of nonresponsiveness to haloperidol, amelioration of ballistic movements was observed only a few days after the initiation of clozapine therapy (50 mg/day). Our report suggests that clozapine may be a valuable alternative for patients with hemiballism.
偏身投掷症是一种相对罕见的运动亢进性疾病;治疗主要基于抗精神病药物和减少多巴胺释放的药物。我们报告了两名偏身投掷症患者的病例。在对氟哌啶醇治疗1个月无反应后,氯氮平治疗(50毫克/天)开始仅几天后,弹道运动就有改善。我们的报告表明,氯氮平可能是偏身投掷症患者的一种有价值的替代治疗药物。